Sana Alajmovic comments on Q2 in BioStock interview

In an interview with BioStock, Enzymatica's CEO Sana Alajmovic expands on the company's interim report for the second quarter of 2026 and shares more about Enzymatica's efforts to build the next phase of its international growth.

In the interview, Sana discusses how Enzymatica is working to drive long-term international growth through an expanding partner pipeline, a strengthened commercial focus, and continued efforts to build relationships with leading international players. She also highlights the company's increased focus on the Nordic markets and explains how Enzymatica's strong scientific documentation continues to be a key driver in discussions with potential partners.

"We are not building just for the next quarter – we are building for long-term, sustainable international growth," says Sana Alajmovic in the interview.

Read the full interview on BioStock here